Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Z288507-5mg | 5mg | In stock | $137.90 | |
Z288507-10mg | 10mg | In stock | $226.90 | |
Z288507-25mg | 25mg | In stock | $503.90 | |
Z288507-50mg | 50mg | In stock | $939.90 | |
Z288507-100mg | 100mg | In stock | $1,583.90 |
CaV3.x blocker
Synonyms | 4-(((3-Chloro-5-fluorobenzoyl)amino)methyl)-N-(1,1-dimethylethyl)-1-piperidineacetamide | PRAX944 | PRAX-944 | PTFE rod, 3.18mm (0.125in) dia | BDBM50192689 | CS-0078307 | 1199236-64-0 | 4-[[(3-Chloro-5-fluorobenzoyl)amino)methyl]-N-(1,1-dimethylethyl)-1- |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Selective T-type Ca2+channel blocker (IC50values are 50 to 160 nM for hCav3.1, hCav3.2 and hCav3.3). Exhibits 50 to 600 fold selectivity for Cav3.x channels over related ion channels (Cav1.2, hERG and Nav1.5). Has no effect on action potential properties |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | CHANNEL BLOCKER |
Mechanism of action | Channel blocker of Ca v3.1;Channel blocker of Ca v3.2;Channel blocker of Ca v3.3 |
Product Description | Product Introduction Z944 is a T-type calcium channel blocker. Z944 delays the progression of seizures in the amygdala kindling model. Z944 disrupts prepulse inhibition in both epileptic and non-epileptic rats. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | N-[[1-[2-(tert-butylamino)-2-oxoethyl]piperidin-4-yl]methyl]-3-chloro-5-fluorobenzamide |
---|---|
INCHI | InChI=1S/C19H27ClFN3O2/c1-19(2,3)23-17(25)12-24-6-4-13(5-7-24)11-22-18(26)14-8-15(20)10-16(21)9-14/h8-10,13H,4-7,11-12H2,1-3H3,(H,22,26)(H,23,25) |
InChi Key | JOCLITFYIMJMNK-UHFFFAOYSA-N |
Canonical SMILES | CC(C)(C)NC(=O)CN1CCC(CC1)CNC(=O)C2=CC(=CC(=C2)Cl)F |
Isomeric SMILES | CC(C)(C)NC(=O)CN1CCC(CC1)CNC(=O)C2=CC(=CC(=C2)Cl)F |
PubChem CID | 44540045 |
Molecular Weight | 383.89 |
PubChem CID | 44540045 |
---|---|
CAS Registry No. | 1199236-64-0 |
RCSB PDB Ligand | DZR |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
I2222239 | Certificate of Analysis | Jul 13, 2022 | Z288507 |
I2222240 | Certificate of Analysis | Jul 13, 2022 | Z288507 |
I2222241 | Certificate of Analysis | Jul 13, 2022 | Z288507 |
I2222242 | Certificate of Analysis | Jul 13, 2022 | Z288507 |
I2222243 | Certificate of Analysis | Jul 13, 2022 | Z288507 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 38.39, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 38.39, Max Conc. mM: 100 |
---|---|
Melt Point(°C) | 122-124°C |